A detailed history of Piershale Financial Group, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Piershale Financial Group, Inc. holds 348 shares of JNJ stock, worth $51,173. This represents 0.04% of its overall portfolio holdings.

Number of Shares
348
Previous 347 0.29%
Holding current value
$51,173
Previous $53,000 7.55%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 06, 2023

BUY
$154.35 - $166.11 $154 - $166
1 Added 0.29%
348 $57,000
Q1 2023

Apr 12, 2023

BUY
$151.05 - $180.26 $151 - $180
1 Added 0.29%
347 $53,000
Q4 2022

Jan 13, 2023

BUY
$160.2 - $179.79 $55,429 - $62,207
346 New
346 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $384B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Piershale Financial Group, Inc. Portfolio

Follow Piershale Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Piershale Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Piershale Financial Group, Inc. with notifications on news.